Literature DB >> 17592365

Knowledge, attitudes and practice styles of North American pediatricians regarding gastroesophageal reflux disease.

Diego M Diaz1, Harland S Winter, Richard B Colletti, George D Ferry, Colin D Rudolph, Steven J Czinn, William Cochran, Benjamin D Gold.   

Abstract

BACKGROUND: The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition launched a provider and public education campaign in 2002 to raise awareness of gastroesophageal reflux disease (GERD). To determine the effectiveness of campaign messages, we conducted a knowledge, attitudes, and practice styles (KAPS) survey of pediatric providers. Understanding the spectrum of management styles of GERD in children is critical to achieve better health outcomes and reduce health care costs.
MATERIALS AND METHODS: The KAPS questionnaire was administered to 6000 randomly selected members of the American Academy of Pediatrics.
RESULTS: A total of 1245 members responded; 82% worked in a primary care setting and 18% in subspecialty practices. Overall, 66% of the members order diagnostic testing in routine practice, 54% start testing for GERD in neonates, and 38% start testing after 1 month of age. The most common tests ordered were barium esophagram (45%) and esophageal pH monitoring (37%). GERD treatment with acid suppression before ordering diagnostic testing was a choice of 82% of the respondents. However, 19% believed acid suppression was best achieved by H2 blockers. If acid suppression was indicated, then only 36% followed guideline recommendations for therapy duration and 52% followed guideline recommendations for dosing. Antireflux surgery was recommended only as a last resort by 92%. Overall, 69% of providers believed the amount of GERD-related information available was not enough. Respondents who were not aware of available GERD practice guidelines ranged from 74% to 92%.
CONCLUSIONS: Pediatric providers appear to frequently order diagnostic testing and treatment for GERD, yet knowledge about evidence-based GERD management among this random sample appeared limited. Moreover, a significant number of providers were not aware of different guideline publications.

Entities:  

Mesh:

Year:  2007        PMID: 17592365     DOI: 10.1097/MPG.0b013e318054b0dd

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  13 in total

1.  Drugs for the treatment of gastro-oesophageal reflux: in search of clear evidence-based indications.

Authors:  Federico Marchetti; Jenny Bua; Alessandro Ventura
Journal:  Arch Dis Child       Date:  2007-12       Impact factor: 3.791

2.  Hospital variation in rates of concurrent fundoplication during gastrostomy enteral access procedures.

Authors:  Anne M Stey; Charles D Vinocur; R Lawrence Moss; Bruce L Hall; Mark E Cohen; Kari Kraemer; Clifford Y Ko; Brian D Kenney; Loren Berman
Journal:  Surg Endosc       Date:  2018-02-05       Impact factor: 4.584

Review 3.  A review of nonsurgical treatment for the symptom of irritability in infants with GERD.

Authors:  Madalynn Neu; Elizabeth Corwin; Suzanne C Lareau; Cassandra Marcheggiani-Howard
Journal:  J Spec Pediatr Nurs       Date:  2011-11-01       Impact factor: 1.260

4.  Mechanisms of Aerodigestive Symptoms in Infants with Varying Acid Reflux Index Determined by Esophageal Manometry.

Authors:  Carissa R Collins; Kathryn A Hasenstab; Saira Nawaz; Sudarshan R Jadcherla
Journal:  J Pediatr       Date:  2018-11-19       Impact factor: 4.406

5.  Gastroesophageal reflux scintigraphy: interpretation methods and inter-reader agreement.

Authors:  Murat Tuncel; Pınar Ozgen Kıratlı; Tamer Aksoy; Murat Fani Bozkurt
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

6.  A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease.

Authors:  Robert M Ward; Gregory L Kearns; Brinda Tammara; Phyllis Bishop; Molly A O'Gorman; Laura P James; Mitchell H Katz; Mary K Maguire; Natalie Rath; Xu Meng; Gail M Comer
Journal:  J Clin Pharmacol       Date:  2010-09-17       Impact factor: 3.126

7.  Pharmacodynamics and safety of pantoprazole in neonates, preterm infants, and infants aged 1 through 11 months with a clinical diagnosis of gastroesophageal reflux disease.

Authors:  Jaroslaw Kierkus; Wanda Furmaga-Jablonska; Janice E Sullivan; Elmer S David; Dan L Stewart; Natalie Rath; Caifeng Fu; Wenjin Wang; Mary K Maguire; Gail M Comer
Journal:  Dig Dis Sci       Date:  2010-07-07       Impact factor: 3.199

8.  Pediatric specialists' beliefs about gastroesophageal reflux disease in premature infants.

Authors:  Catherine A Golski; Ellen S Rome; Richard J Martin; Scott H Frank; Sarah Worley; Zhiyuan Sun; Anna Maria Hibbs
Journal:  Pediatrics       Date:  2009-12-14       Impact factor: 7.124

9.  Italian survey on general pediatricians' approach to children with gastroesophageal reflux symptoms.

Authors:  Paolo Quitadamo; Erasmo Miele; Angelo Alongi; Francesco Paolo Brunese; Maria Elisabetta Di Cosimo; Dante Ferrara; Silvia Gambotto; Adima Lamborghini; Maddalena Mercuri; Angela Pasinato; Renato Sansone; Concetta Vitale; Alberto Villani; Annamaria Staiano
Journal:  Eur J Pediatr       Date:  2014-07-06       Impact factor: 3.183

10.  Short- and long-term antireflux and asthma medication use in children after nissen fundoplication.

Authors:  Steven L Lee
Journal:  Perm J       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.